Skip to main content
Ajay Gopal, MD, Oncology, Seattle, WA, UW Medicine/University of Washington Medical Center

AjayKumarGopalMD

Oncology Seattle, WA

Hematologic Oncology

Professor, Medicine, University of Washington School of Medicine: Member, Fred Hutchinson Cancer Research Center; Clinical Research Director- Hematologic Malignancies- Seattle Cancer Care Alliance

Dr. Gopal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gopal's full profile

Already have an account?

  • Office

    Seattle Cancer Care Alliance (UW/FHCRC)
    825 Eastlake Avenue East
    Seattle, WA 98109
    Phone+1 206-606-1000
  • Is this information wrong?

Summary

  • Dr. Ajay Gopal is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including University of Washington Medical Center and Seattle Cancer Care Alliance. He received his medical degree from Emory University School of Medicine and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology, Hodgkin’s lymphoma, non-Hodgkin’s Lymphoma, CLL, transplant, and cellular therapy.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1997 - 2000
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1993 - 1996
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1993

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1997 - 2024
  • NC State Medical License
    NC State Medical License 1996 - 1998
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Translating Anti-CD19 CAR T-cell Therapy into Clinical Practice for relapsed/refractory Diffuse Large B-cell Lymphoma  
    Mazyar Shadman, Ajay K Gopal, Victor A Chow, Blood

Abstracts/Posters

  • High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Ibrutinib Selects for Cells with Elevated Reactive Oxygen Species and Downregulated Phosphatases
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Indolent Lymphomas: The Marathon Has a New Course 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Oral Duvelisib Potential New Option for Indolent Non-Hodgkin Lymphoma
    Oral Duvelisib Potential New Option for Indolent Non-Hodgkin LymphomaFebruary 27th, 2019
  • One Family, Two Sides of Cancer
    One Family, Two Sides of CancerOctober 6th, 2017
  • Ibrutinib Add-on 'Almost Certainly' Saves Lives in DLBCL
    Ibrutinib Add-on 'Almost Certainly' Saves Lives in DLBCLNovember 12th, 2021
  • Join now to see all

Grant Support

  • Radioimmunotherapy For LymphomaNational Cancer Institute2011
  • Radiolabeled Antibody Therapy Of B-Cell LymphomaNational Cancer Institute2005–2009
  • Proapoptotic Therapy For B-Cell NON Hodgkin'S LymphomaNational Cancer Institute2006–2007
  • Optimizing Radioimmunotherapy For NON Hodgkin'S LymphomaNational Cancer Institute2000–2005

Professional Memberships

Hospital Affiliations